19.73 USD
-1.15 (-5.51%)
Overall SMLR gets a fundamental rating of 5 out of 10. We evaluated SMLR against 188 industry peers in the Health Care Equipment & Supplies industry. While SMLR belongs to the best of the industry regarding profitability, there are concerns on its financial health. SMLR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
SMLR had positive earnings in the past year.
SMLR had a positive operating cash flow in the past year.
SMLR had positive earnings in each of the past 5 years.
SMLR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SMLR's Return On Assets of 7.09% is amongst the best of the industry. SMLR outperforms 87.77% of its industry peers.
Looking at the Return On Equity, with a value of 9.66%, SMLR belongs to the top of the industry, outperforming 85.11% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.92%, SMLR is in the better half of the industry, outperforming 67.02% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SMLR is significantly above the industry average of 8.71%.
The 3 year average ROIC (20.14%) for SMLR is well above the current ROIC(0.92%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROIC | 0.92% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
1.3 Margins
SMLR has a better Profit Margin (86.20%) than 98.94% of its industry peers.
In the last couple of years the Profit Margin of SMLR has grown nicely.
With a decent Operating Margin value of 12.16%, SMLR is doing good in the industry, outperforming 79.79% of the companies in the same industry.
SMLR's Operating Margin has improved in the last couple of years.
SMLR's Gross Margin of 90.91% is amongst the best of the industry. SMLR outperforms 97.34% of its industry peers.
In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SMLR is creating value.
Compared to 1 year ago, SMLR has more shares outstanding
SMLR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SMLR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
SMLR has an Altman-Z score of 1.72. This is a bad value and indicates that SMLR is not financially healthy and even has some risk of bankruptcy.
SMLR has a Altman-Z score (1.72) which is in line with its industry peers.
SMLR has a debt to FCF ratio of 7.90. This is a slightly negative value and a sign of low solvency as SMLR would need 7.90 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.90, SMLR is doing good in the industry, outperforming 73.94% of the companies in the same industry.
SMLR has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.25, SMLR is in line with its industry, outperforming 55.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Altman-Z | 1.72 |
ROIC/WACC0.11
WACC8.7%
2.3 Liquidity
SMLR has a Current Ratio of 0.60. This is a bad value and indicates that SMLR is not financially healthy enough and could expect problems in meeting its short term obligations.
SMLR has a Current ratio of 0.60. This is amonst the worse of the industry: SMLR underperforms 92.55% of its industry peers.
A Quick Ratio of 0.58 indicates that SMLR may have some problems paying its short term obligations.
With a Quick ratio value of 0.58, SMLR is not doing good in the industry: 92.02% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 220.88% over the past year.
The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.44%.
Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
Revenue 1Y (TTM)-17.44%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
3.2 Future
The Earnings Per Share is expected to decrease by -29.01% on average over the next years. This is quite bad
Based on estimates for the next years, SMLR will show a very negative growth in Revenue. The Revenue will decrease by -16.29% on average per year.
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.54%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SMLR is valuated cheaply with a Price/Earnings ratio of 2.25.
Based on the Price/Earnings ratio, SMLR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of SMLR to the average of the S&P500 Index (25.65), we can say SMLR is valued rather cheaply.
The Price/Forward Earnings ratio is 241.79, which means the current valuation is very expensive for SMLR.
63.83% of the companies in the same industry are more expensive than SMLR, based on the Price/Forward Earnings ratio.
SMLR is valuated expensively when we compare the Price/Forward Earnings ratio to 34.45, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.25 | ||
| Fwd PE | 241.79 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SMLR is valued a bit cheaper than 64.36% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SMLR indicates a rather cheap valuation: SMLR is cheaper than 82.45% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.53 | ||
| EV/EBITDA | 70 |
4.3 Compensation for Growth
SMLR has an outstanding profitability rating, which may justify a higher PE ratio.
SMLR's earnings are expected to decrease with -29.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
5. Dividend
5.1 Amount
No dividends for SMLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:SMLR (11/25/2025, 2:43:47 PM)
19.73
-1.15 (-5.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.06%
Inst Owner Change5.54%
Ins Owners4.93%
Ins Owner Change0.32%
Market Cap298.71M
Revenue(TTM)56.29M
Net Income(TTM)37.05M
Analysts82.22
Price Target76.84 (289.46%)
Short Float %15.6%
Short Ratio1.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-23.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)152.63%
EPS NY rev (1m)0%
EPS NY rev (3m)107.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.25 | ||
| Fwd PE | 241.79 | ||
| P/S | 6.95 | ||
| P/FCF | 24.53 | ||
| P/OCF | 23.97 | ||
| P/B | 0.78 | ||
| P/tB | N/A | ||
| EV/EBITDA | 70 |
EPS(TTM)8.76
EY44.4%
EPS(NY)0.08
Fwd EY0.41%
FCF(TTM)0.8
FCFY4.08%
OCF(TTM)0.82
OCFY4.17%
SpS2.84
BVpS25.32
TBVpS-7.49
PEG (NY)N/A
PEG (5Y)0.09
Graham Number70.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROCE | 1.08% | ||
| ROIC | 0.92% | ||
| ROICexc | 0.95% | ||
| ROICexgc | N/A | ||
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% | ||
| FCFM | 28.34% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexgc growth 3Y32.01%
ROICexgc growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Debt/EBITDA | 16.92 | ||
| Cap/Depr | 60.82% | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 218.98% | ||
| Profit Quality | 32.88% | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 1.72 |
F-Score3
WACC8.7%
ROIC/WACC0.11
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.44%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
Revenue Next Year-43.54%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-75.28%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-342.47%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-37.74%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-42.82%
OCF growth 3Y14.98%
OCF growth 5Y13.91%
SEMLER SCIENTIFIC INC / SMLR FAQ
What is the ChartMill fundamental rating of SEMLER SCIENTIFIC INC (SMLR) stock?
ChartMill assigns a fundamental rating of 5 / 10 to SMLR.
What is the valuation status for SMLR stock?
ChartMill assigns a valuation rating of 6 / 10 to SEMLER SCIENTIFIC INC (SMLR). This can be considered as Fairly Valued.
How profitable is SEMLER SCIENTIFIC INC (SMLR) stock?
SEMLER SCIENTIFIC INC (SMLR) has a profitability rating of 9 / 10.
What is the valuation of SEMLER SCIENTIFIC INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SEMLER SCIENTIFIC INC (SMLR) is 2.25 and the Price/Book (PB) ratio is 0.78.